CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancer (Q37819435)
Jump to navigation
Jump to search
scientific article published on December 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancer |
scientific article published on December 2010 |
Statements
1 reference
CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancer (English)
1 reference
José Baselga
1 reference
1 December 2010
1 reference
1 reference
Identifiers
1 reference